Search reports, ask a question, or jump to a page.
The problem
Intervention: Study examining whether CMV infection explains growth and neurodevelopmental outcomes
Who it was tested with: 317 children in Botswana followed prospectively from pregnancy through 24 months; subgroups of HIV-exposed uninfected (HEU) and HIV-unexposed uninfected (HUU) children.
Experience from people who deliver programmes: stories, case studies and lessons learned. Valuable for understanding how and why, and for spotting what to test next, but not a measure of effect.
"We tested 18-month child plasma samples from all available children for anti-HCMV IgG. We evaluated the association between positive (vs. negative) child CMV status at 18 months, and child growth... and neurodevelopment at 24 months of age." The study specifically tested whether CMV infection status correlates with documented growth and development outcomes and found no such associations, suggesting CMV is not the mechanism behind growth delays in exposed children.
Observational design cannot establish causation. The study does not identify the actual mechanism causing poor outcomes in HEU children. Cross-sectional CMV testing at one timepoint limits understanding of infection dynamics.
Across countries and designs
1 study · 1 country
